CD137 Deficiency Because of Two Novel Biallelic TNFRSF9 Mutations in a Patient Presenting with Severe EBV‐associated Lymphoproliferative Disease

CLINICAL & TRANSLATIONAL IMMUNOLOGY(2023)

引用 0|浏览5
摘要
Increasing evidence indicates that some germline genetic mutations that impair pathways required for robust host immune surveillance against EBV infection may result in an extremely high susceptibility to EBV‐associated lymphoproliferative disease (EBV+ LPD). TNFRSF9 encodes a vital costimulatory molecule that enhances CD8+ T‐cell proliferation, survival and cytolytic activity. To date, no relevant case resulting from TNFRSF9 heterozygous mutations has been identified.
更多
查看译文
关键词
EBV infection,EBV-associated lymphoproliferative disease,germline genetic mutation,primary immunodeficiency,TNFRSF9
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
0
您的评分 :

暂无评分

数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn